{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:37:23Z","timestamp":1773797843654,"version":"3.50.1"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10753-023-01812-7","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T07:03:16Z","timestamp":1682060596000},"page":"1161-1176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Crucial Roles and Research Advances of cGAS-STING Pathway in Cutaneous Disorders"],"prefix":"10.1007","volume":"46","author":[{"given":"Cong","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanyao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mindan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"issue":"6","key":"1812_CR1","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/jid.2013.446","volume":"134","author":"RJ Hay","year":"2014","unstructured":"Hay, R.J., N.E. Johns, H.C. Williams, et al. 2014. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. The Journal of Investigative Dermatology 134 (6): 1527\u20131534.","journal-title":"The Journal of Investigative Dermatology"},{"issue":"5","key":"1812_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/jamadermatol.2016.5538","volume":"153","author":"C Karimkhani","year":"2017","unstructured":"Karimkhani, C., R.P. Dellavalle, L.E. Coffeng, et al. 2017. Global skin disease morbidity and mortality: an update from the global burden of disease study 2013. JAMA Dermatology 153 (5): 406\u2013412.","journal-title":"JAMA Dermatology"},{"key":"1812_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.asoc.2019.105725","volume":"84","author":"TY Tan","year":"2019","unstructured":"Tan, T.Y., L. Zhang, and C.P. Lim. 2019. Intelligent skin cancer diagnosis using improved particle swarm optimization and deep learning models. Applied Soft Computing 84: 105725.","journal-title":"Applied Soft Computing"},{"issue":"10","key":"1812_CR4","first-page":"656","volume":"96","author":"A Saguil","year":"2017","unstructured":"Saguil, A., S. Kane, M. Mercado, et al. 2017. Herpes zoster and postherpetic neuralgia: prevention and management. American Family Physician 96 (10): 656\u2013663.","journal-title":"American Family Physician"},{"issue":"5","key":"1812_CR5","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/jama.2018.20181","volume":"321","author":"D Grennan","year":"2019","unstructured":"Grennan, D. 2019. Genital warts. Journal of the American Medical Association 321 (5): 520.","journal-title":"Journal of the American Medical Association"},{"issue":"6","key":"1812_CR6","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/bjd.18785","volume":"182","author":"ZCC Fuxench","year":"2020","unstructured":"Fuxench, Z.C.C. 2020. Pain in atopic dermatitis: it\u2019s time we addressed this symptom further. British Journal of Dermatology 182 (6): 1326\u20131327.","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"1812_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1080\/09546634.2020.1818678","volume":"33","author":"J Maghfour","year":"2022","unstructured":"Maghfour, J., S. Ly, W. Haidari, et al. 2022. Treatment of keratosis pilaris and its variants: a systematic review. The Journal of Dermatological Treatment 33 (3): 1231\u20131242.","journal-title":"The Journal of Dermatological Treatment"},{"issue":"5","key":"1812_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold, M., D. Singh, M. Laversanne, et al. 2022. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatology 158 (5): 495\u2013503.","journal-title":"JAMA Dermatology"},{"issue":"11","key":"1812_CR9","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1158\/2326-6066.CIR-19-0229","volume":"7","author":"R Falahat","year":"2019","unstructured":"Falahat, R., P. Perez-Villarroel, A.W. Mailloux, et al. 2019. STING signaling in melanoma cells shapes antigenicity and can promote antitumor T-cell activity. Cancer Immunology Research 7 (11): 1837\u20131848.","journal-title":"Cancer Immunology Research"},{"key":"1812_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bbrc.2022.04.085","volume":"611","author":"Z Feng","year":"2022","unstructured":"Feng, Z., C. Zang, L. Zhang, et al. 2022. STING activation promotes inflammatory response and delays skin wound healing in diabetic mice. Biochemical and Biophysical Research Communications 611: 126\u2013131.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"1812_CR11","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.3390\/ijms24044128","volume":"24","author":"M Pyclik","year":"2023","unstructured":"Pyclik, M., J. Durslewicz, J.A. Papinska, et al. 2023. STING agonist-induced skin inflammation is exacerbated with prior systemic innate immune activation. International Journal of Molecular Sciences 24 (4): 4128.","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"1812_CR12","doi-asserted-by":"publisher","first-page":"mjac005","DOI":"10.1093\/jmcb\/mjac005","volume":"14","author":"Z Hong","year":"2022","unstructured":"Hong, Z., J. Mei, H. Guo, et al. 2022. Intervention of cGAS-STING signaling in sterile inflammatory diseases. Journal of Molecular Cell Biology 14 (2): mjac005.","journal-title":"Journal of Molecular Cell Biology"},{"issue":"10","key":"1812_CR13","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni.3558","volume":"17","author":"Q Chen","year":"2016","unstructured":"Chen, Q., L. Sun, and Z.J. Chen. 2016. Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing. Nature Immunology 17 (10): 1142\u20131149.","journal-title":"Nature Immunology"},{"issue":"9","key":"1812_CR14","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41581-022-00589-6","volume":"18","author":"S Skopelja-Gardner","year":"2022","unstructured":"Skopelja-Gardner, S., J. An, and K.B. Elkon. 2022. Role of the cGAS-STING pathway in systemic and organ-specific diseases. Nature Reviews. Nephrology 18 (9): 558\u2013572.","journal-title":"Nature Reviews. Nephrology"},{"key":"1812_CR15","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun, L., J. Wu, F. Du, et al. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339: 786\u2013791.","journal-title":"Science"},{"issue":"11","key":"1812_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41576-019-0151-1","volume":"20","author":"M Motwani","year":"2019","unstructured":"Motwani, M., S. Pesiridis, and K.A. Fitzgerald. 2019. DNA Sensing by the cGAS-STING Pathway in Health and Disease. Nature Reviews Genetics 20 (11): 657\u2013674.","journal-title":"Nature Reviews Genetics"},{"issue":"9","key":"1812_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","volume":"21","author":"KP Hopfner","year":"2020","unstructured":"Hopfner, K.P., and V. Hornung. 2020. Molecular mechanisms and cellular functions of cGAS-STING signalling. Nature Reviews Molecular Cell Biology 21 (9): 501\u2013521.","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"6152","key":"1812_CR18","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1126\/science.1244040","volume":"341","author":"XD Li","year":"2013","unstructured":"Li, X.D., J. Wu, D. Gao, et al. 2013. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341 (6152): 1390\u20131394.","journal-title":"Science"},{"issue":"6","key":"1812_CR19","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.chom.2015.05.004","volume":"17","author":"RO Watson","year":"2015","unstructured":"Watson, R.O., S.L. Bell, D.A. MacDuff, et al. 2015. The cytosolic sensor cGAS detects Mycobacterium tuberculosis DNA to induce type i interferons and activate autophagy. Cell Host & Microbe 17 (6): 811\u2013819.","journal-title":"Cell Host & Microbe"},{"issue":"4","key":"1812_CR20","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201949799","volume":"21","author":"JS Riley","year":"2020","unstructured":"Riley, J.S., and S.W. Tait. 2020. Mitochondrial DNA in inflammation and immunity. EMBO Reports 21 (4): e49799.","journal-title":"EMBO Reports"},{"issue":"7267","key":"1812_CR21","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08467","volume":"461","author":"SP Jackson","year":"2009","unstructured":"Jackson, S.P., and J. Bartek. 2009. The DNA-damage response in human biology and disease. Nature 461 (7267): 1071\u20131078.","journal-title":"Nature"},{"issue":"7668","key":"1812_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature23449","volume":"548","author":"KJ Mackenzie","year":"2017","unstructured":"Mackenzie, K.J., P. Carroll, C.A. Martin, et al. 2017. cGAS surveillance of micronuclei links genome instability to innate immunity. Nature 548 (7668): 461\u2013465.","journal-title":"Nature"},{"issue":"3","key":"1812_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.celrep.2014.01.003","volume":"6","author":"X Zhang","year":"2014","unstructured":"Zhang, X., J. Wu, F. Du, et al. 2014. The cytosolic DNA sensor cGAS forms an oligomeric complex with DNA and undergoes switch like conformational changes in the activation loop. Cell Reports 6 (3): 421\u2013430.","journal-title":"Cell Reports"},{"issue":"6","key":"1812_CR24","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.immuni.2013.10.019","volume":"39","author":"X Li","year":"2013","unstructured":"Li, X., C. Shu, G. Yi, et al. 2013. Cyclic GMP-AMP synthase is activated by double-stranded DNA-induced oligomerization. Immunity 39 (6): 1019\u20131031.","journal-title":"Immunity"},{"issue":"2","key":"1812_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.molcel.2013.05.022","volume":"51","author":"X Zhang","year":"2013","unstructured":"Zhang, X., H. Shi, J. Wu, et al. 2013. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Molecular Cell 51 (2): 226\u2013235.","journal-title":"Molecular Cell"},{"issue":"6121","key":"1812_CR26","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.1229963","volume":"339","author":"J Wu","year":"2013","unstructured":"Wu, J., L. Sun, X. Chen, et al. 2013. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339 (6121): 826\u2013830.","journal-title":"Science"},{"issue":"7454","key":"1812_CR27","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature12306","volume":"498","author":"A Ablasser","year":"2013","unstructured":"Ablasser, A., M. Goldeck, T. Cavlar, et al. 2013. cGAS produces a 2\u2019-5\u2019-linked cyclic dinucleotide second messenger that activates STING. Nature 498 (7454): 380\u2013384.","journal-title":"Nature"},{"issue":"7748","key":"1812_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41586-019-0998-5","volume":"567","author":"G Shang","year":"2019","unstructured":"Shang, G., C. Zhang, Z.J. Chen, et al. 2019. Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP-AMP. Nature 567 (7748): 389\u2013393.","journal-title":"Nature"},{"issue":"214","key":"1812_CR29","doi-asserted-by":"publisher","first-page":"ra20","DOI":"10.1126\/scisignal.2002521","volume":"5","author":"Y Tanaka","year":"2012","unstructured":"Tanaka, Y., and Z.J. Chen. 2012. STING specifies IRF3 phosphorylation by TBK1 in the Cytosolic DNA signaling pathway. Science Signaling 5 (214): ra20.","journal-title":"Science Signaling"},{"issue":"6227","key":"1812_CR30","doi-asserted-by":"publisher","first-page":"aaa2630","DOI":"10.1126\/science.aaa2630","volume":"347","author":"S Liu","year":"2015","unstructured":"Liu, S., X. Cai, J. Wu, et al. 2015. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347 (6227): aaa2630.","journal-title":"Science"},{"issue":"7713","key":"1812_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","volume":"559","author":"SM Haag","year":"2018","unstructured":"Haag, S.M., M.F. Gulen, L. Reymond, et al. 2018. Targeting STING with covalent small-molecule inhibitors. Nature 559 (7713): 269\u2013273.","journal-title":"Nature"},{"issue":"7748","key":"1812_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41586-019-1000-2","volume":"567","author":"C Zhang","year":"2019","unstructured":"Zhang, C., G. Shang, X. Gui, et al. 2019. Structural basis of STING binding with and phosphorylation by TBK1. Nature 567 (7748): 394\u2013398.","journal-title":"Nature"},{"issue":"10","key":"1812_CR33","doi-asserted-by":"publisher","first-page":"5328","DOI":"10.1128\/JVI.00037-14","volume":"88","author":"T Abe","year":"2014","unstructured":"Abe, T., and G.N. Barber. 2014. Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-kappaB activation through TBK1. Journal of Virology 88 (10): 5328\u20135341.","journal-title":"Journal of Virology"},{"issue":"1","key":"1812_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2019.11.008","volume":"97","author":"Y Mizutani","year":"2020","unstructured":"Mizutani, Y., A. Kanbe, H. Ito, et al. 2020. Activation of STING signaling accelerates skin wound healing. Journal of Dermatological Science 97 (1): 21\u201329.","journal-title":"Journal of Dermatological Science"},{"issue":"22","key":"1812_CR35","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108234","volume":"40","author":"MA Beck","year":"2021","unstructured":"Beck, M.A., H. Fischer, L.M. Grabner, et al. 2021. DNA hypomethylation leads to cGAS-induced autoinflammation in the epidermis. EMBO Journal 40 (22): e108234.","journal-title":"EMBO Journal"},{"key":"1812_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115495","volume":"418","author":"T Wu","year":"2021","unstructured":"Wu, T., J. Gao, W. Liu, et al. 2021. NLRP3 protects mice from radiation-induced colon and skin damage via attenuating cGAS-STING signaling. Toxicology and Applied Pharmacology 418: 115495.","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"10","key":"1812_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24631","volume":"36","author":"M Zhou","year":"2022","unstructured":"Zhou, M., X. Cheng, W. Zhu, et al. 2022. Activation of cGAS-STING pathway - A possible cause of myofiber atrophy\/necrosis in dermatomyositis and immune-mediated necrotizing myopathy. Journal of Clinical Laboratory Analysis 36 (10): e24631.","journal-title":"Journal of Clinical Laboratory Analysis"},{"key":"1812_CR38","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3389\/fimmu.2019.01440","volume":"10","author":"LJ Zhang","year":"2019","unstructured":"Zhang, L.J. 2019. Type1 Interferons Potential initiating factors linking skin wounds with psoriasis pathogenesis. Frontiers in Immunology 10: 1440.","journal-title":"Frontiers in Immunology"},{"issue":"24","key":"1812_CR39","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1111\/bph.15673","volume":"178","author":"Y Pan","year":"2021","unstructured":"Pan, Y., Y. You, L. Sun, et al. 2021. The STING antagonist H-151 ameliorates psoriasis via suppression of STING\/NF-kB-mediated inflammation. British Journal of Pharmacology 178 (24): 4907\u20134922.","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"1812_CR40","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jid.2021.08.430","volume":"142","author":"Y Yu","year":"2022","unstructured":"Yu, Y., X. Xue, W. Tang, et al. 2022. Cytosolic DNA-mediated STING-dependent inflammation contributes to the progression of psoriasis. The Journal of Investigative Dermatology 142 (3): 898\u2013906.","journal-title":"The Journal of Investigative Dermatology"},{"issue":"8","key":"1812_CR41","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1111\/jcmm.17236","volume":"26","author":"X Li","year":"2022","unstructured":"Li, X., Z. Zhang, Y. Yu, et al. 2022. Activation of the STING-IRF3 pathway involved in psoriasis with diabetes mellitus. Journal of Cellular and Molecular Medicine 26 (8): 2139\u20132151.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"1","key":"1812_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00281-014-0452-6","volume":"37","author":"S Nakamizo","year":"2015","unstructured":"Nakamizo, S., G. Egawa, T. Honda, et al. 2015. Commensal bacteria and cutaneous immunity. Seminars in Immunopathology 37 (1): 73\u201380.","journal-title":"Seminars in Immunopathology"},{"issue":"5","key":"1812_CR43","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/bjd.15390","volume":"177","author":"RD Bjerre","year":"2017","unstructured":"Bjerre, R.D., J. Bandier, L. Skov, et al. 2017. The role of the skin microbiome in atopic dermatitis: a systematic review. British Journal of Dermatology 177 (5): 1272\u20131278.","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"1812_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s40168-018-0558-5","volume":"6","author":"AM O'Neill","year":"2018","unstructured":"O\u2019Neill, A.M., and R.L. Gallo. 2018. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. Microbiome 6 (1): 177.","journal-title":"Microbiome"},{"issue":"5","key":"1812_CR45","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/exd.14528","volume":"31","author":"S Wang","year":"2022","unstructured":"Wang, S., R. Wang, Y. Song, et al. 2022. Dysbiosis of nail microbiome in patients with psoriasis. Experimental Dermatology 31 (5): 800\u2013806.","journal-title":"Experimental Dermatology"},{"issue":"14","key":"1812_CR46","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1016\/j.cell.2021.05.020","volume":"184","author":"DS Lima-Junior","year":"2021","unstructured":"Lima-Junior, D.S., S.R. Krishnamurthy, N. Bouladoux, et al. 2021. Endogenous retroviruses promote homeostatic and inflammatory responses to the microbiota. Cell 184 (14): 3794\u20133811.","journal-title":"Cell"},{"issue":"3","key":"1812_CR47","first-page":"515","volume":"86","author":"L Skudalski","year":"2022","unstructured":"Skudalski, L., R. Waldman, P.E. Kerr, et al. 2022. Melanoma: an update on systemic therapies. JAMA Dermatology 86 (3): 515\u2013524.","journal-title":"JAMA Dermatology"},{"issue":"22","key":"1812_CR48","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1158\/0008-5472.CAN-16-1404","volume":"76","author":"T Xia","year":"2016","unstructured":"Xia, T., H. Konno, and G.N. Barber. 2016. Recurrent loss of STING signaling in melanoma correlates with susceptibility to viral oncolysis. Cancer Research 76 (22): 6747\u20136759.","journal-title":"Cancer Research"},{"issue":"15","key":"1812_CR49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2013598118","volume":"118","author":"R Falahat","year":"2021","unstructured":"Falahat, R., A. Berglund, R.M. Putney, et al. 2021. Epigenetic reprogramming of tumor cell\u2013intrinsic STING function sculpts antigenicity and T cell recognition of melanoma. Proceedings of the National Academy of Sciences 118 (15): e2013598118.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"1812_CR50","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jid.2021.08.437","volume":"142","author":"T Xu","year":"2022","unstructured":"Xu, T., J. Dai, L. Tang, et al. 2022. EZH2 inhibitor enhances the STING agonist-induced antitumor immunity in melanoma. The Journal of Investigative Dermatology 142 (4): 1158\u20131170.","journal-title":"The Journal of Investigative Dermatology"},{"issue":"5","key":"1812_CR51","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","volume":"41","author":"SR Woo","year":"2014","unstructured":"Woo, S.R., M.B. Fuertes, L. Corrales, et al. 2014. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 41 (5): 830\u2013842.","journal-title":"Immunity"},{"issue":"3","key":"1812_CR52","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139333","volume":"131","author":"M Hu","year":"2021","unstructured":"Hu, M., M. Zhou, X. Bao, et al. 2021. ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS\/STING activation. The Journal of Clinical Investigation 131 (3): e139333.","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"1812_CR53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41565-018-0342-5","volume":"14","author":"D Shae","year":"2019","unstructured":"Shae, D., K.W. Becker, P. Christov, et al. 2019. Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy. Nature Nanotechnology 14 (3): 269\u2013278.","journal-title":"Nature Nanotechnology"},{"issue":"1","key":"1812_CR54","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1080\/21655979.2021.1972198","volume":"12","author":"Z Ma","year":"2021","unstructured":"Ma, Z., Q. Xiong, H. Xia, et al. 2021. Carboplatin activates the cGAS-STING pathway by upregulating the TREX-1 (three prime repair exonuclease 1) expression in human melanoma. Bioengineered 12 (1): 6448\u20136458.","journal-title":"Bioengineered"},{"issue":"8","key":"1812_CR55","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s00262-015-1713-5","volume":"64","author":"Z Wang","year":"2015","unstructured":"Wang, Z., and E. Celis. 2015. STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice. Cancer Immunology, Immunotherapy 64 (8): 1057\u20131066.","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"1812_CR56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jconrel.2015.08.026","volume":"216","author":"T Nakamura","year":"2015","unstructured":"Nakamura, T., H. Miyabe, M. Hyodo, et al. 2015. Liposomes loaded with a sting pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma. Journal of Controlled Release 216: 149\u2013157.","journal-title":"Journal of Controlled Release"},{"issue":"20","key":"1812_CR57","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","volume":"371","author":"GV Long","year":"2014","unstructured":"Long, G.V., D. Stroyakovskiy, H. Gogas, et al. 2014. Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma. New England Journal of Medicine 371 (20): 1877\u20131888.","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"1812_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40257-020-00572-6","volume":"22","author":"O Dulgar","year":"2021","unstructured":"Dulgar, O., T. Kutuk, and Z. Eroglu. 2021. Mechanisms of resistance to BRAF-targeted melanoma therapies. American Journal of Clinical Dermatology 22 (1): 1\u201310.","journal-title":"American Journal of Clinical Dermatology"},{"issue":"9\u201310","key":"1812_CR59","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1101\/gad.333864.119","volume":"34","author":"J Yue","year":"2020","unstructured":"Yue, J., R. Vendramin, F. Liu, et al. 2020. Targeted chemotherapy overcomes drug resistance in melanoma. Genes & Development 34 (9\u201310): 637\u2013649.","journal-title":"Genes & Development"},{"issue":"1","key":"1812_CR60","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12943-017-0667-y","volume":"16","author":"G Cesi","year":"2017","unstructured":"Cesi, G., G. Walbrecq, A. Zimmer, et al. 2017. ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells. Molecular Cancer 16 (1): 102.","journal-title":"Molecular Cancer"},{"issue":"3","key":"1812_CR61","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41419-018-0340-4","volume":"9","author":"R Khamari","year":"2018","unstructured":"Khamari, R., A. Trinh, P.E. Gabert, et al. 2018. Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors. Cell Death & Disease 9 (3): 325.","journal-title":"Cell Death & Disease"},{"issue":"12","key":"1812_CR62","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1083\/jcb.201701107","volume":"216","author":"NJ Hos","year":"2017","unstructured":"Hos, N.J., R. Ganesan, S. Guti\u00e9rrez, et al. 2017. Type I interferon enhances necroptosis of Salmonella Typhimurium\u2013infected macrophages by impairing antioxidative stress responses. Journal of Cell Biology 216 (12): 4107\u20134121.","journal-title":"Journal of Cell Biology"},{"issue":"7736","key":"1812_CR63","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","volume":"564","author":"JM Ramanjulu","year":"2018","unstructured":"Ramanjulu, J.M., G.S. Pesiridis, J. Yang, et al. 2018. Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature 564 (7736): 439\u2013443.","journal-title":"Nature"},{"key":"1812_CR64","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3389\/fonc.2020.00758","volume":"10","author":"S Chipurupalli","year":"2020","unstructured":"Chipurupalli, S., R. Ganesan, S.P. Dhanabal, et al. 2020. Pharmacological STING activation is a potential alternative to overcome drug-resistance in melanoma. Frontiers in Oncology 10: 758.","journal-title":"Frontiers in Oncology"},{"issue":"16","key":"1812_CR65","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","volume":"381","author":"J Larkin","year":"2019","unstructured":"Larkin, J., V. Chiarion-Sileni, R. Gonzalez, et al. 2019. Five-year survival with combined nivolumab and ipilimumab in advanced melanoma. New England Journal of Medicine 381 (16): 1535\u20131546.","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"1812_CR66","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","volume":"37","author":"AJ Schoenfeld","year":"2020","unstructured":"Schoenfeld, A.J., and M.D. Hellmann. 2020. Acquired resistance to immune checkpoint inhibitors. Cancer Cell 37 (4): 443\u2013455.","journal-title":"Cancer Cell"},{"issue":"12","key":"1812_CR67","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1158\/1078-0432.CCR-20-3365","volume":"27","author":"TT Nguyen","year":"2021","unstructured":"Nguyen, T.T., L. Ramsay, M. Ahanfeshar-Adams, et al. 2021. Mutations in the IFN\u03b3-JAK-STAT pathway causing resistance to immune checkpoint inhibitors in melanoma increase sensitivity to oncolytic virus treatment. Clinical Cancer Research 27 (12): 3432\u20133442.","journal-title":"Clinical Cancer Research"},{"issue":"13","key":"1812_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110582","volume":"38","author":"N Srour","year":"2022","unstructured":"Srour, N., O.D. Villarreal, S. Hardikar, et al. 2022. PRMT7 ablation stimulates anti-tumor immunity and sensitizes melanoma to immune checkpoint blockade. Cell Reports 38 (13): 110582.","journal-title":"Cell Reports"},{"key":"1812_CR69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-cancerbio-030518-055636","volume":"3","author":"S Yum","year":"2019","unstructured":"Yum, S., M. Li, A.E. Frankel, et al. 2019. Roles of the cGAS-STING pathway in cancer immunosurveillance and immunotherapy. Annual Review of Cancer Biology 3: 323\u2013344.","journal-title":"Annual Review of Cancer Biology"},{"issue":"22","key":"1812_CR70","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.3390\/cancers13225603","volume":"13","author":"S Sato","year":"2021","unstructured":"Sato, S., Y. Sawada, and M. Nakamura. 2021. STING signaling and skin cancers. Cancers (Basel) 13 (22): 5603.","journal-title":"Cancers (Basel)"},{"key":"1812_CR71","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jconrel.2014.04.004","volume":"184","author":"H Miyabe","year":"2014","unstructured":"Miyabe, H., M. Hyodo, T. Nakamura, et al. 2014. A new adjuvant delivery system \u2018cyclic di-GMP\/YSK05 liposome\u2019 for cancer immunotherapy. Journal of Controlled Release 184: 20\u201327.","journal-title":"Journal of Controlled Release"},{"issue":"7","key":"1812_CR72","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002852","volume":"9","author":"T Nakamura","year":"2021","unstructured":"Nakamura, T., T. Sato, R. Endo, et al. 2021. STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation. Journal for Immunotherapy of Cancer 9 (7): e002852.","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"1","key":"1812_CR73","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1038\/s41467-019-08620-4","volume":"10","author":"L Lama","year":"2019","unstructured":"Lama, L., C. Adura, W. Xie, et al. 2019. Development of human cGAS-specific small molecule inhibitors for repression of dsDNA triggered interferon expression. Nature Communications 10 (1): 2261.","journal-title":"Nature Communications"},{"issue":"1","key":"1812_CR74","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41467-017-00833-9","volume":"8","author":"J Vincent","year":"2017","unstructured":"Vincent, J., C. Adura, P. Gao, et al. 2017. Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice. Nature Communications 8 (1): 750.","journal-title":"Nature Communications"},{"issue":"1","key":"1812_CR75","doi-asserted-by":"publisher","first-page":"7604","DOI":"10.1038\/s41598-020-64348-y","volume":"10","author":"C Wiser","year":"2020","unstructured":"Wiser, C., B. Kim, J. Vincent, et al. 2020. Small molecule inhibition of human cGAS reduces total cGAMP output and cytokine expression in cells. Science and Reports 10 (1): 7604.","journal-title":"Science and Reports"},{"issue":"11","key":"1812_CR76","doi-asserted-by":"publisher","first-page":"7667","DOI":"10.1021\/acs.jmedchem.1c00398","volume":"64","author":"J Tan","year":"2021","unstructured":"Tan, J., B. Wu, T. Chen, et al. 2021. Synthesis and pharmacological evaluation of tetrahydro-\u03b3-carboline derivatives as potent anti-inflammatory agents targeting cyclic GMP-AMP synthase. Journal of Medicinal Chemistry 64 (11): 7667\u20137690.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"1812_CR77","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.18565","volume":"3","author":"B Platt","year":"2020","unstructured":"Platt, B., E. Belarski, J. Manaloor, et al. 2020. Comparison of risk of recrudescent fever in children with Kawasaki disease treated with intravenous immunoglobulin and low-dose vs high-dose aspirin. JAMA Network Open 3 (1): e1918565.","journal-title":"JAMA Network Open"},{"issue":"1","key":"1812_CR78","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jid.2020.06.011","volume":"141","author":"JA D\u2019Orazio","year":"2021","unstructured":"D\u2019Orazio, J.A. 2021. Aspirin\u2019s protective effects highlight the role of inflammation in UV-induced skin damage and carcinogenesis. The Journal of Investigative Dermatology 141 (1): 10\u201311.","journal-title":"The Journal of Investigative Dermatology"},{"issue":"6","key":"1812_CR79","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.cell.2019.01.016","volume":"176","author":"J Dai","year":"2019","unstructured":"Dai, J., Y.J. Huang, X. He, et al. 2019. Acetylation blocks cGAS activity and inhibits self-DNA-induced autoimmunity. Cell 176 (6): 1447\u20131460.","journal-title":"Cell"},{"issue":"19","key":"1812_CR80","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1039\/C5CC10446G","volume":"52","author":"C Opoku-Temeng","year":"2016","unstructured":"Opoku-Temeng, C., and H.O. Sintim. 2016. Potent inhibition of cyclic diadenylate monophosphate cyclase by the antiparasitic drug, suramin. Chemical Communications (Cambridge, England) 52 (19): 3754\u20133757.","journal-title":"Chemical Communications (Cambridge, England)"},{"issue":"11","key":"1812_CR81","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.4155\/fmc-2017-0322","volume":"10","author":"M Wang","year":"2018","unstructured":"Wang, M., M.A. Sooreshjani, C. Mikek, et al. 2018. Suramin potently inhibits cGAMP synthase, cGAS, in THP1 cells to modulate IFN-\u03b2 levels. Future Medicinal Chemistry 10 (11): 1301\u20131317.","journal-title":"Future Medicinal Chemistry"},{"issue":"4","key":"1812_CR82","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/eji.201747338","volume":"48","author":"F Steinhagen","year":"2018","unstructured":"Steinhagen, F., T. Zillinger, K. Peukert, et al. 2018. Suppressive oligodeoxynucleotides containing TTAGGG motifs Inhibit cGAS activation in human monocytes. European Journal of Immunology 48 (4): 605\u2013611.","journal-title":"European Journal of Immunology"},{"issue":"4","key":"1812_CR83","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911002","volume":"12","author":"Q Li","year":"2020","unstructured":"Li, Q., Y. Cao, C. Dang, et al. 2020. Inhibition of double-strand DNA-sensing cGAS ameliorates brain injury after ischemic stroke. EMBO Molecular Medicine 12 (4): e11002.","journal-title":"EMBO Molecular Medicine"},{"key":"1812_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.655637","volume":"12","author":"L Chu","year":"2021","unstructured":"Chu, L., C. Li, Y. Li, et al. 2021. Perillaldehyde inhibition of cGAS reduces dsDNA-induced interferon response. Frontiers in Immunology 12: 655637.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"1812_CR85","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41590-018-0262-4","volume":"20","author":"ZS Liu","year":"2019","unstructured":"Liu, Z.S., H. Cai, W. Xue, et al. 2019. G3BP1 promotes DNA binding and activation of cGAS. Nature Immunology 20 (1): 18\u201328.","journal-title":"Nature Immunology"},{"issue":"10","key":"1812_CR86","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.4049\/jimmunol.2001111","volume":"206","author":"H Cai","year":"2021","unstructured":"Cai, H., X. Liu, F. Zhang, et al. 2021. G3BP1 inhibition alleviates intracellular nucleic acid-induced autoimmune responses. The Journal of Immunology 206 (10): 2453\u20132467.","journal-title":"The Journal of Immunology"},{"issue":"11","key":"1812_CR87","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.1093\/nar\/gkab451","volume":"49","author":"R Valentin","year":"2021","unstructured":"Valentin, R., C. Wong, A.S. Alharbi, et al. 2021. Sequence-dependent inhibition of cGAS and TLR9 DNA sensing by 2\u2019-O-methyl gapmer oligonucleotides. Nucleic Acids Research 49 (11): 6082\u20136099.","journal-title":"Nucleic Acids Research"},{"key":"1812_CR88","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.58037","volume":"9","author":"SR Cuddy","year":"2020","unstructured":"Cuddy, S.R., A.R. Schinlever, S. Dochnal, et al. 2020. Neuronal hyperexcitability is a DLK-dependent trigger of herpes simplex virus reactivation that can be induced by IL-1. eLife 9: e58037.","journal-title":"eLife"},{"issue":"30","key":"1812_CR89","doi-asserted-by":"publisher","first-page":"eabo4435","DOI":"10.1126\/sciadv.abo4435","volume":"8","author":"M Guellil","year":"2022","unstructured":"Guellil, M., L. van Dorp, S.A. Inskip, et al. 2022. Ancient herpes simplex 1 genomes reveal recent viral structure in Eurasia. Science Advances 8 (30): eabo4435.","journal-title":"Science Advances"},{"key":"1812_CR90","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.virol.2019.01.006","volume":"529","author":"S Cer\u00f3n","year":"2019","unstructured":"Cer\u00f3n, S., B.J. North, S.A. Taylor, et al. 2019. The STING agonist 5,6-dimethylxanthenone-4-acetic acid (DMXAA) stimulates an antiviral state and protects mice against herpes simplex virus. Virology 529: 23\u201328.","journal-title":"Virology"},{"key":"1812_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104933","volume":"183","author":"Q Zhu","year":"2020","unstructured":"Zhu, Q., H. Hu, H. Liu, et al. 2020. A synthetic STING agonist inhibits the replication of human parainfluenza virus 3 and rhinovirus 16 through distinct mechanisms. Antiviral Research 183: 104933.","journal-title":"Antiviral Research"},{"issue":"59","key":"1812_CR92","doi-asserted-by":"publisher","first-page":"eabi9007","DOI":"10.1126\/sciimmunol.abi9007","volume":"6","author":"M Li","year":"2021","unstructured":"Li, M., M. Ferretti, B. Ying, et al. 2021. Pharmacological activation of STING blocks SARS-CoV-2 infection. Science Immunology 6 (59): eabi9007.","journal-title":"Science Immunology"},{"issue":"50","key":"1812_CR93","doi-asserted-by":"publisher","first-page":"15408","DOI":"10.1073\/pnas.1512832112","volume":"112","author":"O Demaria","year":"2015","unstructured":"Demaria, O., A. De Gassart, S. Coso, et al. 2015. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity. Proceedings of the National Academy of Sciences 112 (50): 15408\u201315413.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"10","key":"1812_CR94","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1172\/JCI125413","volume":"129","author":"H Yang","year":"2019","unstructured":"Yang, H., W.S. Lee, S.J. Kong, et al. 2019. STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade. The Journal of Clinical Investigation 129 (10): 4350\u20134364.","journal-title":"The Journal of Clinical Investigation"},{"issue":"7","key":"1812_CR95","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1073\/pnas.1621363114","volume":"114","author":"H Wang","year":"2017","unstructured":"Wang, H., S. Hu, X. Chen, et al. 2017. cGAS is essential for the antitumor effect of immune checkpoint blockade. Proceedings of the National Academy of Sciences 114 (7): 1637\u20131642.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"1812_CR96","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imr.12765","volume":"290","author":"BA Flood","year":"2019","unstructured":"Flood, B.A., E.F. Higgs, S. Li, et al. 2019. STING pathway agonism as a cancer therapeutic. Immunological Reviews 290 (1): 24\u201338.","journal-title":"Immunological Reviews"},{"issue":"1","key":"1812_CR97","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jcmgh.2021.01.018","volume":"12","author":"EP Vonderhaar","year":"2021","unstructured":"Vonderhaar, E.P., N.S. Barnekow, D. McAllister, et al. 2021. STING activated tumor-intrinsic type I interferon signaling promotes CXCR3 dependent antitumor immunity in pancreatic cancer. Cellular and Molecular Gastroenterology and Hepatology 12 (1): 41\u201358.","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"issue":"28","key":"1812_CR98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2111003119","volume":"119","author":"G Berger","year":"2022","unstructured":"Berger, G., E.H. Knelson, J.L. Jimenez-Macias, et al. 2022. STING activation promotes robust immune response and NK cell\u2013mediated tumor regression in glioblastoma models. Proceedings of the National Academy of Sciences 119 (28): e2111003119.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"1812_CR99","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","volume":"28","author":"F Meric-Bernstam","year":"2022","unstructured":"Meric-Bernstam, F., R.F. Sweis, F.S. Hodi, et al. 2022. Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas. Clinical Cancer Research 28 (4): 677\u2013688.","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"1812_CR100","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001906","volume":"9","author":"M Chelvanambi","year":"2021","unstructured":"Chelvanambi, M., R.J. Fecek, J.L. Taylor, et al. 2021. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. Journal for Immunotherapy of Cancer 9 (2): e001906.","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"8","key":"1812_CR101","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003246","volume":"9","author":"CR Ager","year":"2021","unstructured":"Ager, C.R., A. Boda, K. Rajapakshe, et al. 2021. High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege. Journal for Immunotherapy of Cancer 9 (8): e003246.","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"20","key":"1812_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2019.126640","volume":"29","author":"CR Ager","year":"2019","unstructured":"Ager, C.R., H. Zhang, Z. Wei, et al. 2019. Discovery of IACS-8803 and IACS-8779, potent agonists of stimulator of interferon genes (STING) with robust systemic antitumor efficacy. Bioorganic & Medicinal Chemistry Letters 29 (20): 126640.","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"7","key":"1812_CR103","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1021\/cb400264n","volume":"8","author":"S Kim","year":"2013","unstructured":"Kim, S., L. Li, Z. Maliga, et al. 2013. Anticancer flavonoids are mouse-selective STING agonists. ACS Chemical Biology 8 (7): 1396\u20131401.","journal-title":"ACS Chemical Biology"},{"issue":"1","key":"1812_CR104","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s40425-019-0573-5","volume":"7","author":"W Jing","year":"2019","unstructured":"Jing, W., D. McAllister, E.P. Vonderhaar, et al. 2019. STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models. Journal for Immunotherapy of Cancer 7 (1): 115.","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"7","key":"1812_CR105","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","volume":"11","author":"L Corrales","year":"2015","unstructured":"Corrales, L., L.H. Glickman, S.M. McWhirter, et al. 2015. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Reports 11 (7): 1018\u20131030.","journal-title":"Cell Reports"},{"issue":"6506","key":"1812_CR106","doi-asserted-by":"publisher","first-page":"eaba6098","DOI":"10.1126\/science.aba6098","volume":"369","author":"BS Pan","year":"2020","unstructured":"Pan, B.S., S.A. Perera, J.A. Piesvaux, et al. 2020. An orally available non-nucleotide STING agonist with antitumor activity. Science 369 (6506): eaba6098.","journal-title":"Science"},{"issue":"7","key":"1812_CR107","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106065","volume":"40","author":"J Tian","year":"2021","unstructured":"Tian, J., D. Zhang, V. Kurbatov, et al. 2021. 5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING. EMBO Journal 40 (7): e106065.","journal-title":"EMBO Journal"},{"key":"1812_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100523","volume":"296","author":"KM McAndrews","year":"2021","unstructured":"McAndrews, K.M., S.P.Y. Che, V.S. LeBleu, et al. 2021. Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity. Journal of Biological Chemistry 296: 100523.","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"1812_CR109","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41551-020-00675-9","volume":"5","author":"S Li","year":"2021","unstructured":"Li, S., M. Luo, Z. Wang, et al. 2021. Prolonged activation of innate immune pathways by a polyvalent STING agonist. Nature Biomedical Engineering 5 (5): 455\u2013466.","journal-title":"Nature Biomedical Engineering"},{"issue":"8","key":"1812_CR110","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.202100133","volume":"21","author":"Q Zhou","year":"2021","unstructured":"Zhou, Q., Y. Zhou, T. Li, et al. 2021. Nanoparticle-mediated STING agonist delivery for enhanced cancer immunotherapy. Macromolecular Bioscience 21 (8): e2100133.","journal-title":"Macromolecular Bioscience"},{"issue":"22","key":"1812_CR111","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.120638","volume":"3","author":"N Cheng","year":"2018","unstructured":"Cheng, N., R. Watkins-Schulz, R.D. Junkins, et al. 2018. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1\u2013insensitive models of triple-negative breast cancer. JCI Insight 3 (22): e120638.","journal-title":"JCI Insight"},{"issue":"3","key":"1812_CR112","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1039\/D0BM00870B","volume":"9","author":"K Li","year":"2021","unstructured":"Li, K., Y. Ye, L. Liu, et al. 2021. The lipid platform increases the activity of STING agonists to synergize checkpoint blockade therapy against melanoma. Biomaterials Science 9 (3): 765\u2013773.","journal-title":"Biomaterials Science"},{"key":"1812_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bioactmat.2022.02.029","volume":"16","author":"H Zheng","year":"2022","unstructured":"Zheng, H., B. Guo, X. Qiu, et al. 2022. Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy. Bioactive Materials 16: 1\u201311.","journal-title":"Bioactive Materials"},{"issue":"6","key":"1812_CR114","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41563-022-01251-z","volume":"21","author":"EL Dane","year":"2022","unstructured":"Dane, E.L., A. Belessiotis-Richards, C. Backlund, et al. 2022. STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer Immunity. Nature Materials 21 (6): 710\u2013720.","journal-title":"Nature Materials"},{"key":"1812_CR115","doi-asserted-by":"crossref","unstructured":"Zhang, K., C. Qi, and K. Cai. 2022. Manganese-based tumor immunotherapy. Advanced Materials, e2205409.","DOI":"10.1002\/adma.202205409"},{"issue":"4","key":"1812_CR116","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.immuni.2018.03.017","volume":"48","author":"C Wang","year":"2018","unstructured":"Wang, C., Y. Guan, M. Lv, et al. 2018. Manganese increases the sensitivity of the cGAS-STING pathway for double-stranded DNA and is required for the host defense against DNA viruses. Immunity 48 (4): 675\u2013687.","journal-title":"Immunity"},{"issue":"4","key":"1812_CR117","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1021\/acsnano.9b06111","volume":"14","author":"L Hou","year":"2020","unstructured":"Hou, L., C. Tian, Y. Yan, et al. 2020. Manganese-based nanoactivator optimizes cancer immunotherapy via enhancing innate immunity. ACS Nano 14 (4): 3927\u20133940.","journal-title":"ACS Nano"},{"issue":"17","key":"1812_CR118","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202006970","volume":"17","author":"C Chen","year":"2021","unstructured":"Chen, C., Y. Tong, Y. Zheng, et al. 2021. Cytosolic delivery of thiolated Mn-cGAMP nanovaccine to enhance the antitumor immune responses. Small (Weinheim an der Bergstrasse, Germany) 17 (17): e2006970.","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"issue":"8","key":"1812_CR119","doi-asserted-by":"publisher","first-page":"2100065","DOI":"10.1002\/adtp.202100065","volume":"4","author":"M Gao","year":"2021","unstructured":"Gao, M., Y. Xie, K. Lei, et al. 2021. A manganese phosphate nanocluster activates the cGAS-STING pathway for enhanced cancer immunotherapy. Advanced Therapeutics 4 (8): 2100065.","journal-title":"Advanced Therapeutics"},{"issue":"11","key":"1812_CR120","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","volume":"30","author":"M Lv","year":"2020","unstructured":"Lv, M., M. Chen, R. Zhang, et al. 2020. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy. Cell Research 30 (11): 966\u2013979.","journal-title":"Cell Research"},{"issue":"9","key":"1812_CR121","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout, A., J.D. Katz, S. Venkatraman, et al. 2021. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nature Reviews Immunology 21 (9): 548\u2013569.","journal-title":"Nature Reviews Immunology"},{"issue":"4","key":"1812_CR122","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1152\/ajprenal.00554.2020","volume":"320","author":"W Gong","year":"2021","unstructured":"Gong, W., L. Lu, Y. Zhou, et al. 2021. The novel STING antagonist H151 ameliorates cisplatin-induced acute kidney injury and mitochondrial dysfunction. American Journal of Physiology-Renal Physiology 320 (4): 608\u2013616.","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"7899","key":"1812_CR123","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41586-022-04421-w","volume":"603","author":"JD Domizio","year":"2022","unstructured":"Domizio, J.D., M.F. Gulen, F. Saidoune, et al. 2022. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature 603 (7899): 145\u2013151.","journal-title":"Nature"},{"issue":"12","key":"1812_CR124","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1016\/j.celrep.2018.11.097","volume":"25","author":"S Li","year":"2018","unstructured":"Li, S., Z. Hong, Z. Wang, et al. 2018. The cyclopeptide astin C specifically inhibits the innate immune CDN sensor STING. Cell Reports 25 (12): 3405\u20133421.","journal-title":"Cell Reports"},{"key":"1812_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103314","volume":"66","author":"T Prabakaran","year":"2021","unstructured":"Prabakaran, T., A. Troldborg, S. Kumpunya, et al. 2021. A STING antagonist modulating the interaction with STIM1 blocks ER-to-Golgi trafficking and inhibits lupus pathology. eBioMedicine 66: 103314.","journal-title":"eBioMedicine"},{"issue":"24","key":"1812_CR126","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2105465118","volume":"118","author":"Z Hong","year":"2021","unstructured":"Hong, Z., J. Mei, C. Li, et al. 2021. STING inhibitors target the cyclic dinucleotide binding pocket. Proceedings of the National Academy of Sciences 118 (24): e2105465118.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"1812_CR127","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1021\/acsmedchemlett.8b00466","volume":"10","author":"T Siu","year":"2018","unstructured":"Siu, T., M.D. Altman, G.A. Baltus, et al. 2018. Discovery of a novel cGAMP competitive ligand of the inactive form of STING. ACS Medicinal Chemistry Letters 10 (1): 92\u201397.","journal-title":"ACS Medicinal Chemistry Letters"},{"issue":"2","key":"1812_CR128","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.bbrc.2019.11.107","volume":"522","author":"S Harabuchi","year":"2020","unstructured":"Harabuchi, S., A. Kosaka, Y. Yajima, et al. 2020. Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma. Biochemical and Biophysical Research Communications 522 (2): 408\u2013414.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"1812_CR129","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1038\/s41467-021-22572-8","volume":"12","author":"TJ Hayman","year":"2021","unstructured":"Hayman, T.J., M. Baro, T. MacNeil, et al. 2021. STING enhances cell death through regulation of reactive oxygen species and DNA damage. Nature Communications 12 (1): 2327.","journal-title":"Nature Communications"},{"issue":"13","key":"1812_CR130","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02211-20","volume":"95","author":"NA Krump","year":"2021","unstructured":"Krump, N.A., R. Wang, W. Liu, et al. 2021. Merkel cell polyomavirus infection induces an antiviral innate immune response in human dermal fibroblasts. Journal of Virology 95 (13): e0221120.","journal-title":"Journal of Virology"},{"issue":"24","key":"1812_CR131","doi-asserted-by":"publisher","first-page":"13730","DOI":"10.1073\/pnas.1919690117","volume":"117","author":"W Liu","year":"2020","unstructured":"Liu, W., G.B. Kim, N.A. Krump, et al. 2020. Selective reactivation of STING signaling to target Merkel cell carcinoma. Proceedings of the National Academy of Sciences 117 (24): 13730\u201313739.","journal-title":"Proceedings of the National Academy of Sciences"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01812-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-023-01812-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01812-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T20:42:13Z","timestamp":1744144933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-023-01812-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":131,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1812"],"URL":"https:\/\/doi.org\/10.1007\/s10753-023-01812-7","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"assertion":[{"value":"14 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DECLARATIONS"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}